MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koh, A. S.
Right arrow Articles by Ballatori, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koh, A. S.
Right arrow Articles by Ballatori, N.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ACETYLCYSTEINE

Vol. 62, Issue 4, 921-926, October 2002

Identification of a Mechanism by Which the Methylmercury Antidotes N-Acetylcysteine and Dimercaptopropanesulfonate Enhance Urinary Metal Excretion: Transport by the Renal Organic Anion Transporter-1

Albert S. Koh, Tracey A. Simmons-Willis, John B. Pritchard, Steven M. Grassl, and Nazzareno Ballatori

Department of Environmental Medicine, University of Rochester School of Medicine, Rochester, NY (A.S.K., T.A.S.-W., N.B.); Laboratory for Pharmacology and Chemistry, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina (J.B.P.); and Department of Pharmacology, State University of New York Upstate Medical University, Syracuse, New York (S.M.G.)

N-Acetylcysteine (NAC) and dimercaptopropanesulfonate (DMPS) are sulfhydryl-containing compounds that produce a dramatic acceleration of urinary methylmercury (MeHg) excretion in poisoned animals, but the molecular mechanism for this effect is unknown. NAC and DMPS are themselves excreted in urine in high concentrations. The present study tested the hypothesis that the complexes formed between MeHg and these anionic chelating agents are transported from blood into proximal tubule cells by the basolateral membrane organic anion transporters (Oat) 1 and Oat3. Xenopus laevis oocytes expressing rat Oat1 showed increased uptake of [14C]MeHg when complexed with either NAC or DMPS but not when complexed with L-cysteine, glutathione, dimercaptosuccinate, penicillamine, or gamma -glutamylcysteine. In contrast, none of these MeHg complexes were transported by Oat3-expressing oocytes. The apparent Km values for Oat1-mediated transport were 31 ± 2 µM for MeHg-NAC and 9 ± 2 µM for MeHg-DMPS, indicating that these are relatively high-affinity substrates. Oat1-mediated uptake of [14C]MeHg-NAC and [14C]MeHg-DMPS was inhibited by prototypical substrates for Oat1, including p-aminohippurate (PAH), and was trans-stimulated when oocytes were preloaded with 2 mM glutarate but not glutamate. Conversely, efflux of [3H]PAH from Oat1-expressing oocytes was trans-stimulated by glutarate, PAH, NAC, DMPS, MeHg-NAC, MeHg-DMPS, and a mercapturic acid, indicating that these are transported solutes. [3H]PAH uptake was competitively inhibited by NAC (Ki of 2.0 ± 0.3 mM) and DMPS (Ki of 0.10 ± 0.02 mM), providing further evidence that these chelating agents are substrates for Oat1. These results indicate that the MeHg antidotes NAC and DMPS and their mercaptide complexes are transported by Oat1 but are comparatively poor substrates for Oat3. This is the first molecular identification of a transport mechanism by which these antidotes may enhance urinary excretion of toxic metals.


Copyright © 2002 by U.S. Government



This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
G. V. Erives, S. S. Lau, and T. J. Monks
Accumulation of Neurotoxic Thioether Metabolites of 3,4-({+/-})-Methylenedioxymethamphetamine in Rat Brain
J. Pharmacol. Exp. Ther., January 1, 2008; 324(1): 284 - 291.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
N. Bakhiya, M. Batke, J. Laake, B. H. Monien, H. Frank, A. Seidel, W. Engst, and H. Glatt
Directing Role of Organic Anion Transporters in the Excretion of Mercapturic Acids of Alkylated Polycyclic Aromatic Hydrocarbons
Drug Metab. Dispos., October 1, 2007; 35(10): 1824 - 1831.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. S. Madejczyk, D. A. Aremu, T. A. Simmons-Willis, T. W. Clarkson, and N. Ballatori
Accelerated Urinary Excretion of Methylmercury following Administration of Its Antidote N-Acetylcysteine Requires Mrp2/Abcc2, the Apical Multidrug Resistance-Associated Protein
J. Pharmacol. Exp. Ther., July 1, 2007; 322(1): 378 - 384.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. C. Bridges and R. K. Zalups
System B0,+ and the Transport of Thiol-S-Conjugates of Methylmercury
J. Pharmacol. Exp. Ther., November 1, 2006; 319(2): 948 - 956.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. K. Zalups and S. Ahmad
Transport of N-Acetylcysteine S-Conjugates of Methylmercury in Madin-Darby Canine Kidney Cells Stably Transfected with Human Isoform of Organic Anion Transporter 1
J. Pharmacol. Exp. Ther., September 1, 2005; 314(3): 1158 - 1168.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. A. Eraly, K. T. Bush, R. V. Sampogna, V. Bhatnagar, and S. K. Nigam
The Molecular Pharmacology of Organic Anion Transporters: from DNA to FDA?
Mol. Pharmacol., March 1, 2004; 65(3): 479 - 487.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. Lungkaphin, V. Chatsudthipong, K. K. Evans, C. E. Groves, S. H. Wright, and W. H. Dantzler
Interaction of the metal chelator DMPS with OAT1 and OAT3 in intact isolated rabbit renal proximal tubules
Am J Physiol Renal Physiol, January 1, 2004; 286(1): F68 - F76.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics